Latest Business Development News

Page 2 of 38
US1 Critical Minerals ended September with A$65,000 in cash against quarterly operating outflows of A$406,000, leaving an estimated 0.16 quarters of funding. Its proposed transfer of six Tanzanian uranium licences could provide US$1 million on completion, but remains subject to regulatory and other conditions.
Maxwell Dee
Maxwell Dee
30 Oct 2026
RTG Mining says its Mabilo copper and gold project is moving towards a Final Investment Decision, with Glencore financing up to US$30 million of Stage 1 development. Permitting remains the critical hold-up, while fresh drilling at Chanach has produced no assays yet.
Maxwell Dee
Maxwell Dee
30 Oct 2026
I Synergy ended the September quarter with A$44,000 in cash and an estimated 0.76 quarters of funding, before securing A$200,000 in loan funding after quarter-end. Its proposed Macau digital economy partnership remains non-binding, while a prior half-year review flagged material uncertainty around going concern.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Metgasco’s September quarter delivered lower production and revenue, while unrestricted cash covered less than one quarter of operating needs. The company is pursuing recapitalisation as A$7.3 million of debt approaches a December maturity and 30.15 PJe of reserves shifts into contingent resources.
Victor Sage
Victor Sage
30 Oct 2026
Optiscan has moved its InForm and InVue medical-imaging devices into formal US FDA review after a quarter of intensive regulatory and clinical work. The milestone comes with $11.093 million in cash and a reported 3.5 quarters of funding at the latest operating burn rate.
Victor Sage
Victor Sage
30 Oct 2026
Australian Vanadium has moved its flagship project closer to an Optimised Feasibility Study while adding new industrial battery opportunities with Alcoa. But the September quarter also reduced cash to $12.4 million, leaving an estimated 2.5 quarters of funding at the reported spending rate.
Victor Sage
Victor Sage
30 Oct 2026
4DS Memory has completed its acquisition of Jenesys and appointed founder Jaspal Sarai as CEO, combining autonomous-systems software with its ReRAM technology. The company has A$6.6 million in quarter-end cash plus a further A$2 million placement, but has yet to secure a binding customer agreement.
Sophie Babbage
Sophie Babbage
29 Oct 2026
Alcidion has started FY27 with contracted revenue up 38% to $50.0 million, while a major UK expansion and new patient administration product widen its growth case. The company has also reaffirmed that FY27 revenue and underlying EBITDA will exceed FY26, but its capital plan now has several competing demands.
Victor Sage
Victor Sage
29 Oct 2026
Avecho has resumed recruitment for the final cohort of its pivotal Phase III insomnia trial after an interim review supported continuing at the original 519-participant target. The biotechnology company is also pursuing international licensing while holding $5.3 million in cash.
Ada Torres
Ada Torres
28 Oct 2026
Aurora Labs has secured $6 million to expand production of its additively manufactured turbojet systems, with Walkinshaw Group joining the placement as a strategic investor. The raise will fund equipment, production infrastructure and the company’s push from early deliveries towards scaled commercial manufacturing.
Victor Sage
Victor Sage
28 Oct 2026
Equatorial Resources is awaiting a final ICSID ruling on its Congo iron ore dispute, with a decision indicatively possible in the first half of 2027. The company also remains unable to confirm the status of its Guinea permits, while holding A$6.8 million in cash.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Pure Foods Tasmania reported a sharper September quarter, with customer receipts rising to A$1.22 million while operating cash outflow fell to A$311,000. The company remains cash flow negative and reliant on financing capacity, but says the figures mark progress towards a sustainable turnaround.
Victor Sage
Victor Sage
26 Oct 2026

Browse the archive

Full archive